Skip to main content

Serum l-Arginase in Healthy Subjects and Nitric Oxide

  • Chapter
  • First Online:
L-Arginine in Clinical Nutrition

Part of the book series: Nutrition and Health ((NH))

  • 1375 Accesses

Abstract

Blood flow is essential for human to maintain the life and also a very important biosample for physicians and clinical researchers to observe the condition of the human body. The reasons why investigating human serum is important are as follows: (1) human serum is easy to collect, (2) human serum contains various chemicals or biomarkers suitable for diagnosis, and (3) huge quantities of clinical test protocols using serum are already established and even automated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ikemoto M, Tsunekawa S, Tanaka K, et al. Liver-type l-arginase in serum during and after liver transplantation: a novel index in monitoring conditions of the liver graft and its clinical significance. Clin Chim Acta. 1998;271:11–23.

    Google Scholar 

  2. Ikemoto M, Ishida A, Tsunekawa S, et al. Enzyme immunoassay of liver-type l-arginase and its potential clinical application. Clin Chem. 1993;39:794–9.

    Google Scholar 

  3. Durante W, Johnson FK, Johnson RA. l-Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol. 2007;34:906–11.

    Google Scholar 

  4. Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem. 1952;199:91–5.

    CAS  PubMed  Google Scholar 

  5. Geyer JW, Dabich D. Rapid method for determination of l-arginase activity in tissue homogenates. Anal Biochem. 1971;39:412–7.

    Google Scholar 

  6. Xu W, Kaneko FT, Zheng S, et al. Increased l-arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J. 2004;18:1746–8.

    Google Scholar 

  7. Wang SR, Chen ML, Huang MH, et al. Plasma l-arginase concentration measured by an enzyme-linked immunosorbent assay (ELISA) in normal adult population. Clin Biochem. 1993;26:455–60.

    Google Scholar 

  8. Kimura M, Tatsumi KI, Tada H, et al. Enzyme immunoassay for autoantibodies to human liver-type l-arginase and its clinical application. Clin Chem. 2000;46:112–7.

    Google Scholar 

  9. Huang LW, Liu HW, Chang KL. Development of a sandwich ELISA test for l-arginase measurement based on monoclonal antibodies. Hybridoma. 2001;20:53–7.

    Google Scholar 

  10. Ikemoto M, Tsunekawa S, Awane M, et al. A useful ELISA system for human liver-type l-arginase, and its utility in diagnosis of liver diseases. Clin Biochem. 2001;34:455–61.

    Google Scholar 

  11. Ogino K, Murakami I, Wang DH, et al. Evaluation of serum l-arginase I as an oxidative stress biomarker in a healthy Japanese population using a newly established ELISA. Clin Biochem. 2013;46:1717–22.

    Google Scholar 

  12. Vilas-Boas W, Cerqueira BA, Zanette AM, et al. l-Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients. Ann Hematol. 2010;89:877–82.

    Google Scholar 

  13. Kim PS, Iyer RK, Lu KV, et al. Expression of the liver form of l-arginase in erythrocytes. Mol Genet Metab. 2002;76:100–10.

    Google Scholar 

  14. Morris CR, Suh JH, Hagar W, et al. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood. 2008;111:402–10.

    Google Scholar 

  15. Eleftheriadis T, Liakopoulos V, Antoniadi G, et al. l-Arginase type I as a marker of coronary heart disease in hemodialysis patients. Int Urol Nephrol. 2011;43:1187–94.

    Google Scholar 

  16. Ogino K, Takahashi N, Takigawa T, et al. Association of serum l-arginase I with oxidative stress in a healthy population. Free Radic Res. 2011;45:147–55.

    Google Scholar 

  17. Ogino K, Obase Y, Takahashi N, et al. High serum l-arginase I levels in asthma: its correlation with high-sensitivity C-reactive protein. J Asthma. 2011;48:1–7.

    Google Scholar 

  18. Bekpinar S, Gurdol F, Unlucerci Y, et al. Serum levels of l-arginase I are associated with left ventricular function after myocardial infarction. Clin Biochem. 2011;44:1090–3.

    Google Scholar 

  19. El-Hady SB, Farahat MH, Atfy M, et al. Nitric oxide metabolites and l-arginase I levels in β-thalassemic patients: an Egyptian study. Ann Hematol. 2012;91:1193–200.

    Google Scholar 

  20. Ogino K, Wang DH, Kubo M, et al. Association of serum l-arginase I with l-arginine, 3-nitrotyrosine, and exhaled nitric oxide in healthy Japanese workers. Free Radic Res. 2014;48:137–45.

    Google Scholar 

  21. Choudhury B, Srivastava S, Choudhury HH, et al. l-Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India. Tumour Biol. 2014;35:6739–48.

    Google Scholar 

  22. Polat MF, Taysi S, Polat S, et al. Elevated serum l-arginase activity levels in patients with breast cancer. Surg Today. 2003;33:655–61.

    Google Scholar 

  23. Porembska Z, Skwarek A, Mielczarek M, et al. Serum l-arginase activity in postsurgical monitoring of patients with colorectal carcinoma. Cancer. 2002;94:2930–4.

    Google Scholar 

  24. Elgün S, Keskineğe A, Yilmaz E, et al. Evaluation of serum l-arginase activity in benign prostatic hypertrophy and prostatic cancer. Int Urol Nephrol. 1999;31:95–9.

    Google Scholar 

  25. Elgün S, Kumbasar H. Increased serum l-arginase activity in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24:227–32.

    Google Scholar 

  26. Chrzanowska A, Graboń W, Mielczarek-Puta M, et al. Significance of l-arginase determination in body fluids of patients with hepatocellular carcinoma and liver cirrhosis before and after surgical treatment. Clin Biochem. 2014;47:1056–9.

    Google Scholar 

  27. Graboń W, Mielczarek-Puta M, Chrzanowska A, Barańczyk-Kuźma A. l-arginine as a factor increasing l-arginase significance in diagnosis of primary and metastatic colorectal cancer. Clin Biochem. 2009;42:353–7.

    Google Scholar 

  28. Porembska Z, Luboiński G, Chrzanowska A, et al. l-Arginase in patients with breast cancer. Clin Chim Acta. 2003;328:105–11.

    Google Scholar 

  29. del Ara RM, González-Polo RA, Caro A, et al. Diagnostic performance of l-arginase activity in colorectal cancer. Clin Exp Med. 2002;2:53–7.

    Google Scholar 

  30. Tektaş AK, Uslu S, Yalçin AU, et al. Effects of lipoprotein-associated phospholipase A2 on l-arginase/nitric oxide pathway in hemodialysis patients. Ren Fail. 2012;34:738–43.

    Google Scholar 

  31. Kocyigit A, Zeyrek D, Keles H, et al. Relationship among manganese, l-arginase, and nitric oxide in childhood asthma. Biol Trace Elem Res. 2004;102:11–8.

    Google Scholar 

  32. The Human Cytochrome P450 (CYP) Allele Nomenclature Database. http://www.cypalleles.ki.se/. Accessed 26 Sept 2014.

  33. Kline JA, Watts J, Courtney D, et al. Severe pulmonary embolism decreases plasma l-arginine. Eur Respir J. 2014;43:906–9.

    Google Scholar 

  34. Morris Jr SM. Recent advances in l-arginine metabolism: roles and regulation of the l-arginases. Br J Pharmacol. 2009;157:922–30.

    Google Scholar 

  35. Yang BK, Vivas EX, Reiter CD, et al. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic Res. 2003;37:1–10.

    Article  CAS  PubMed  Google Scholar 

  36. Taddei S, Virdis A, Mattei P, et al. Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation. 1996;94:1298–303.

    Google Scholar 

  37. Schulman SP, Becker LC, Kass DA, et al. l-arginine therapy in acute myocardial infarction: the vascular interaction with age in myocardial infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295:58–64.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keiki Ogino MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ogino, K., Takemoto, K. (2017). Serum l-Arginase in Healthy Subjects and Nitric Oxide. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26009-9_14

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-26007-5

  • Online ISBN: 978-3-319-26009-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics